Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

Metformin

225 mg q12, oral PD 0332334 immediate release formulation on Days 1 through 5; Single, oral, 500 mg dose of metformin immediate release

DRUG

Metformin

Single, oral, 500 mg of metformin immediate release

DRUG

PD 0332334

500 mg q12, oral metformin immediate release administered on Days 1 through Day 6 Single, oral, 300 mg dose of PD 0332334 immediate release formulation administered on Day 3

DRUG

PD 0332334

Single, oral, 300 mg dose of PD 0332334 immediate release formulation

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY